Indications of Recruitment Challenges in Research with US Military Service Members: A ClinicalTrials.gov Review

被引:13
|
作者
Cook, Wendy A. [1 ]
Doorenbos, Ardith Z. [2 ]
机构
[1] Naval Med Ctr San Diego, 34800 Bob Wilson Dr, San Diego, CA 92134 USA
[2] Univ Washington, Biobehav Nursing & Hlth Syst, Box 357266, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
CLINICAL-TRIALS;
D O I
10.7205/MILMED-D-16-00225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The success of military-relevant health research often depends on recruiting adequate numbers of U.S. military service members as research participants. Researchers have reported difficulties in recruiting service member research participants. Reviews of ClinicalTrials. gov, an online clinical trial registry of publicly and privately sponsored studies, have identified challenges in participant recruitment and barriers to study completion in various research populations. The purpose of this study was to identify indications of difficulty recruiting U.S. military service members as research participants based on data from study records in ClinicalTrials. gov. Materials and Methods: Records of studies starting between 2005 and 2014 were collected from ClinicalTrials. gov and updated through January 2016. Three hundred and two studies that included >= 25% U.S. military service member research participants were (1) compared to a comparison group of 302 studies, each with <5% service member participants and (2) compared by the proportion of service member participants within studies in the military group ("many" >= 25% but <100% service members and "all" 100% service members). Groups were evaluated and compared for recruitment status; reasons for study withdrawal, termination, or suspension; achievement of >= 85% of the anticipated enrollment; and differences in achieving recruitment goals according to study sponsor. Results: Twelve percent of studies in the military group had been withdrawn, terminated, or suspended; enrollment and funding problems were the most common reasons. The comparison group had 11% of studies withdrawn, terminated, or suspended; the most common reasons were enrollment problems and sponsor decision. All study groups had indications of difficulty adequately achieving participant enrollment goals. Among studies with known anticipated and actual enrollment, approximately half in both the military group (47.9%) and comparison group (50.3%) achieved >= 85% of the anticipated enrollment (p = 0.722). Half of studies with many service members and 44% of studies with all service members achieved >= 85% of the anticipated enrollment (p = 0.600). In comparing the many and all service member subgroups, significant differences were found in the median values for anticipated enrollment and actual enrollment, even when accounting for Bonferroni correction. Evaluations of mean values did not show a statistical difference between the military subgroups. There were no significant differences according to study sponsor (military, academic, Veterans Affairs, National Institutes of Health, nonprofit organization, or industry) for a study achieving or not achieving >= 85% of the anticipated enrollment. Conclusion: This review supports anecdotal reports of difficulty recruiting service members as research participants. However, the findings also indicate that in many regards, there is not much difference in the difficulties recruiting service members versus other research participants. Findings suggest that it is often difficult to recruit research participants regardless of the specific population or type of study sponsor, and that studies with either many or all service member participants have similar achievement of recruitment goals. Findings in this study may be useful for those who design research that includes service members or for those who are apprehensive about including service members in their research.
引用
收藏
页码:E1580 / E1587
页数:8
相关论文
共 50 条
  • [31] Are citations from clinical trials evidence of higher impact research? An analysis of ClinicalTrials.gov
    Mike Thelwall
    Kayvan Kousha
    [J]. Scientometrics, 2016, 109 : 1341 - 1351
  • [32] Patient-Reported Outcomes in Atrial Fibrillation Research Results of a Clinicaltrials.gov Analysis
    Steinberg, Benjamin A.
    Dorian, Paul
    Anstrom, Kevin J.
    Hess, Rachel
    Mark, Daniel B.
    Noseworthy, Peter A.
    Spertus, John A.
    Piccini, Jonathan P.
    [J]. JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (05) : 599 - 605
  • [33] Investigational Medicinal Products for the Inner Ear: Review of Clinical Trial Characteristics in ClinicalTrials.gov
    Le Prell, Colleen G.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY, 2021, 32 (10) : 670 - 694
  • [34] A Decade On: Systematic Review of ClinicalTrials.gov Infectious Disease Trials, 2007-2017
    Jaffe, Ian S.
    Chiswell, Karen
    Tsalik, Ephraim L.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (06):
  • [35] Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry
    Desselas, Emilie
    Pansieri, Claudia
    Leroux, Stephanie
    Bonati, Maurizio
    Jacqz-Aigrain, Evelyne
    [J]. PLOS ONE, 2017, 12 (02):
  • [36] THE CURRENT LANDSCAPE OF THERAPEUTIC CLINICAL TRIALS IN PEDIATRIC BRAIN TUMORS: A REVIEW OF CLINICALTRIALS.GOV
    Hwang, Eugene
    Kuril, Sandeep
    Salcido, Joanne
    [J]. NEURO-ONCOLOGY, 2018, 20 : 81 - 82
  • [37] Are citations from clinical trials evidence of higher impact research? An analysis of ClinicalTrials.gov
    Thelwall, Mike
    Kousha, Kayvan
    [J]. SCIENTOMETRICS, 2016, 109 (02) : 1341 - 1351
  • [38] Discrepancies between ClinicalTrials.gov recruitment status and actual trial status: a cross-sectional analysis
    Jones, Christopher W.
    Safferman, Michelle R.
    Adams, Amanda C.
    Platts-Mills, Timothy F.
    [J]. BMJ OPEN, 2017, 7 (10):
  • [39] Trajectory analysis of drug-research trends in pancreatic cancer on PubMed and ClinicalTrials.gov
    Jeong, Yoo Kyung
    Heo, Go Eun
    Kang, Keun Young
    Yoon, Dong Sup
    Song, Min
    [J]. JOURNAL OF INFORMETRICS, 2016, 10 (01) : 273 - 285
  • [40] Female participation in US oncology clinical trials registered on ClinicalTrials.gov from 2008 to 2020
    Perera, Nirosha D.
    Bellomo, Tiffany R.
    Litt, Henry K.
    Fattahi, Sayeh
    Bell, Alexander
    Stavins, MaKenna A.
    Saleki, Massoud
    Ionescu, Ruxandra
    Shyu, Margaret
    Wang, Max M.
    Tao, Jacqueline
    Sarsour, Nadeen
    Ji, Sunjong
    O'Keefe, Ryan M.
    Pun, Matthew
    Takasugi, Jordan M.
    Steinberg, Jecca R.
    King, Roderick
    Mahipal, Amit
    Turner, Brandon E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)